Saudi Arabia’s Top 10 Leaders for 2026 – Who Has a Vision

The leadership landscape within Saudi Arabia's healthcare sector is undergoing a profound evolution as the Kingdom accelerates its strategic objectives toward Vision 2030. This transformation involves a wide-ranging shift in governance paradigms, operating models, and sectoral contributions that collectively aim to position Saudi Arabia as a regional and global hub for advanced medical care and innovation. The leadership ecosystem reflects a complex interplay between public institutions, private entities, and emerging partnerships that redefine healthcare delivery, financing, and regulation.

In 2026, the focus on measurable impact through operational excellence, digital integration, and population health management has highlighted a cohort of influential leaders shaping the future of healthcare in Saudi Arabia. These individuals exemplify governance philosophies that prioritize accountability, performance metrics, and sustainable growth across multiple healthcare domains—from privatization and corporatization to advanced academic medicine and pharmaceutical sovereignty. Their contributions span critical sectors such as hospital management, biotech innovation, retail pharmacy transformation, and regulatory oversight.

Sectoral leaders in Saudi Arabia’s healthcare landscape are marked by their strategic approaches to operational delivery, public-private collaboration, and pioneering integration of technology aligned with national health priorities. This forward-looking leadership reflects a clear understanding of the Kingdom’s demographic challenges, healthcare demands, and ambition to improve public health outcomes through targeted investment, digital adoption, and value-based care models. As such, the profiles of these top leaders demonstrate a balance between clinical expertise, executive acumen, and policy-driven mandates within the evolving Saudi healthcare environment.

Exploring the profiles of Saudi Arabia's top healthcare leaders for 2026 reveals a unified vision emphasizing the necessity of reliable systems, innovative governance, and sectoral resilience. Their leadership trajectories confirm that achieving national health goals is contingent not solely on futuristic vision but on precise execution, strategic partnerships, and sustained transformation efforts. These leaders collectively represent the forefront of Saudi Arabia’s commitment to healthcare excellence, underpinned by measurable outcomes and governance that aligns with its broader economic and social development strategies.

1. Basim Aljihani: Healthcare Execution Strategist & Operational Excellence Leader Driving National Healthcare Privatization & Delivery

Basim Aljihani plays a central role in Saudi Arabia’s transition from policy frameworks to tangible healthcare outcomes within the National Privatization Strategy. His expertise focuses on translating strategic blueprints into operational realities amid the rollout of over 220 Public-Private Partnership (PPP) contracts valued at SAR 240 billion. Basim’s leadership is instrumental in overseeing the corporatization and performance accountability of 290 hospitals and more than 2,300 primary care centers, emphasizing governance, delivery timelines, and patient outcome alignment.

His operational philosophy positions efficiency as a means to expand capacity by enhancing procurement cycles, digitizing patient triage, and reducing administrative delays. These refinements contribute to a system that generates an estimated $38 billion in value through outsourcing and efficiency, with reinvestment directed toward improving service quality and infrastructure resilience. Basim integrates digital platforms such as the Sehhaty application, used by over 31 million individuals, with disciplined executive leadership to ensure predictive analytics and digital records achieve meaningful clinical and operational impact.

Within the evolving healthcare ecosystem, Basim underscores the private sector’s role as a national execution partner, advocating for collaborative stewardship of universal health insurance delivery. He frames operational excellence as foundational to building trust and advancing value-based care models, where financial sustainability coincides with improved patient-centered outcomes. His background combines executive management acumen with deep experience in healthcare operations and investment alignment, reinforcing his pivotal position in Saudi Arabia’s healthcare reform trajectory.

2. Nasser Al-Huqbani: CEO of the Health Holding Company Leading National Privatization & Corporatization of Saudi Healthcare Assets

Nasser Al-Huqbani stands as a defining figure in Saudi Arabia’s public healthcare transformation, bringing the efficiencies of private-sector models to the government domain. With a career spanning over 25 years, including leadership of the Dr. Sulaiman Al-Habib Medical Group, he now oversees the corporatization of more than 20 Health Clusters comprising 290 hospitals and 2,300 primary care centers. These entities operate as Accountable Care Organizations, advancing financial and administrative independence across the Kingdom’s health system.

Leading efforts aligned with Vision 2030, Nasser’s strategy prioritizes a shift from "sick care" centered on acute hospital intervention to a model emphasizing preventative care delivered within community clusters. He deploys digital innovation by extending his experience launching the region’s first fully digital hospitals to establish AI-driven, unified digital infrastructures throughout the Health Clusters. His role encapsulates the operational execution necessary to transition Saudi Arabia’s public healthcare assets into efficient, accountable units that advance population health and life expectancy goals.

3. H.E. Dr. Majid Al Fayyadh: CEO of King Faisal Specialist Hospital & Research Centre Driving Advanced Academic Medicine & Biotech Innovation

Dr. Majid Al Fayyadh leads one of Saudi Arabia’s most distinguished medical institutions, with King Faisal Specialist Hospital & Research Centre ranking 12th globally among academic medical centers in 2026. His tenure has witnessed the institution’s evolution into a center of excellence in biotech and precision medicine, notably expanding in-house CAR-T cell therapy manufacturing to enhance local cancer treatment accessibility while reducing costs.

Dr. Al Fayyadh has overseen pioneering achievements including world-first fully robotic heart transplants and intracranial tumor resections, reinforcing the hospital’s technological leadership. He managed the hospital’s transition to an independent non-profit foundation, improving financial sustainability and agility in research endeavors. Playing a critical role in the Saudi Human Genome Project, the hospital’s genomic precision programs have enabled early detection of numerous genetic disorders, contributing to national healthcare cost savings.

Under his leadership, KFSHRC integrates AI-assisted clinical decision systems and digital health records across Riyadh, Jeddah, and Madinah campuses, recognized by Newsweek as one of the world’s leading smart hospitals for consecutive years. Dr. Al Fayyadh’s clinical and academic background reinforces his capacity to navigate complex institutional transformations positioning Saudi Arabia at the forefront of high-technology medical care.

4. Eng. Yasser Joharji: CEO of Nahdi Medical Company Spearheading Retail Pharmacy & Omni-Health Systems Integration

Eng. Yasser Joharji leads Nahdi Medical Company’s transformation from a conventional pharmacy chain into an expansive omni-health ecosystem serving 97% of Saudi Arabia’s population. Since assuming the CEO role in 2014, he has driven the expansion of NahdiCare polyclinics, overseeing operations of over 15 clinics across major cities such as Riyadh, Jeddah, and Abha, with patient volumes exceeding 1.4 million by 2025.

Joharji’s strategy balances digital innovation with personal care, positioning online services to contribute approximately 25% of revenue while leveraging AI and data science for chronic disease management and patient adherence. He led strategic partnerships, notably implementing the Wasfaty prescription program in coordination with the National Unified Procurement Company (NUPCO), enhancing nationwide medication access. His focus on supply chain modernization includes integrating renewable energy into Nahdi’s IMDAD distribution center and increasing local healthcare product availability.

Aligned with Vision 2030, his leadership advances preventive health and community wellness initiatives. Eng. Joharji’s background in industrial engineering and extensive experience in consumer sectors underpin his emphasis on purpose-driven leadership and future-ready retail healthcare models.

5. Prof. Dr. Ahmed Aljedai: Vice Chairman and Managing Director of SPIMACO Driving Pharmaceutical Sovereignty & Biotech Localization in Saudi Arabia

Prof. Dr. Ahmed Aljedai leads Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) in its critical objective of pharmaceutical self-sufficiency. Under his stewardship as Managing Director, SPIMACO has progressed in registering over 15 new pharmaceutical products and has shifted focus toward high-value specialties including oncology and advanced biologics.

One of Dr. Aljedai’s notable advancements is operationalizing the SAR 272 million High-Potent Plant, the region’s first dedicated facility for manufacturing complex cancer therapies locally. His leadership also facilitated the launch of the GCC’s first fully integrated biosimilar product, setting a regional precedent in technology transfer and local biologics production. Aligned with the National Biotech Strategy, he has cultivated partnerships critical to securing vaccine and biotech supply independence.

Uncommonly bridging clinical expertise with industrial leadership, Dr. Aljedai maintains a professorship at Alfaisal University and contributes to both academic and operational discourse on clinical pharmacy and transplant pharmacotherapy. His multifaceted role reinforces Saudi Arabia’s ambitions in pharmaceutical innovation and public health security.

6. Dr. Fouziyah Al-Jarallah: Owner & Group CEO of Hayat National Hospitals Group Championing Private Hospital Networks & Female Leadership

Dr. Fouziyah Al-Jarallah stands out as a prominent female leader operating at the intersection of private healthcare management and clinical innovation in Saudi Arabia. Heading Hayat National Hospitals Group, she has overseen a multi-billion SAR expansion, growing the organization to 15 facilities with a capacity of 4,000 beds, particularly targeting underserved regions like Riyadh, Medina, Jazan, and Abha.

Her leadership includes a strategic partnership with GE HealthCare, equipping new hospitals with advanced diagnostic technology such as deep-learning MRI systems. As Vice Chairperson of the National Committee of Private Hospitals, Dr. Al-Jarallah actively aligns private sector capacity with Ministry of Health regional clusters, enhancing patient experience and system cohesion. She advocates for the integration of AI-driven mobile applications that streamline telemedicine, medication delivery, and home care services to reduce administrative burden.

Participating in national human capital strategies, she influences training and retention approaches for healthcare professionals, reinforcing sustainable sector growth. Dr. Al-Jarallah’s clinical expertise in Allergy and Immunology, coupled with her healthcare administration background, positions her as a significant contributor to Saudi Arabia’s private healthcare advancement.

7. Dr. Malek Almoosa: Group CEO of Almoosa Health Group Fostering Integrated Healthcare Ecosystems & Person-Centered Care in Eastern Province

Dr. Malek Almoosa has evolved a family-owned medical enterprise into a publicly traded, expansive healthcare ecosystem prioritized on person-centered care. His leadership culminated in the development of the largest private healthcare complex in Saudi Arabia’s Eastern Province, the Al Moosa Specialist Hospital, featuring 400 beds within a 300,000 square meter facility.

Following a successful IPO, Dr. Almoosa expanded the group's bed capacity significantly, operating facilities that cater to over 1.2 million patients annually. The group achieved the Middle East’s first Planetree Gold Designation for person-centered care, with Dr. Almoosa actively serving on the international board advocating patient experience strategies. He has innovated hospital design through the “Micro-Village” model, integrating therapeutic environments inclusive of nature, hospitality, and retail elements.

His governance role extends to the Health Holding Company Board and the Saudi Commission for Health Specialties, chairing quality and audit committees. Dr. Almoosa’s academic credentials include a Doctorate in Business Administration focusing on healthcare strategy, supplemented by executive education at leading global institutions, underscoring his influence on national health policy and quality standards.

8. Dr. Ahmed Shandal AlEnizi: CEO of Riyadh Third Health Cluster Overseeing Large-Scale Public Health Management & Clinical Integration

Dr. Ahmed Shandal AlEnizi leads one of Saudi Arabia’s largest public health networks, managing over 10,000 employees within the Riyadh Third Health Cluster. His leadership emphasizes cultural transformation from traditional civil service toward clinical accountability and patient-centered efficiency. The cluster encompasses 14 hospitals and more than 150 primary care centers, unified under a single accountable care framework facilitating seamless patient navigation supported by integrated digital health records.

Dr. AlEnizi has expanded bed capacity to nearly 2,000 beds and implemented real-time command center technology to optimize patient flow and reduce emergency department delays. His clinical expertise as a Pediatric Consultant in Pulmonary and Sleep Medicine informs his approach to care model reforms. His role is pivotal in executing the Health Sector Transformation Program, positioning Riyadh Third Health Cluster as a prototype for privatization and value-based healthcare metrics.

His educational background includes medical and specialized training in Canada, complemented by healthcare management credentials and executive leadership education at Harvard and Stanford. Prior senior positions at King Saud Medical City contributed to his operational expertise advancing hospital rankings and service quality.

9. Dr. Reem Bubshait: Executive Director at Council of Health Insurance Shaping Regulatory Governance & Value-Based Care in Saudi Arabia

Dr. Reem Bubshait occupies a central role in transforming Saudi Arabia’s insurance landscape toward a value-based care model. Within the Council of Health Insurance, she integrates clinical outcomes with financial sustainability, ensuring the private insurance market prioritizes high-quality patient recovery over procedural volume. In 2026, she oversees the implementation of the National Platform for Health and Insurance Exchange Services (NPHIES), enhancing claims processing efficiency and reducing administrative challenges nationally.

Dr. Bubshait advances patient-centric initiatives, improving the transparency and comprehensiveness of the Essential Benefits Package, including preventive care, mental health, and chronic disease management. She spearheads the Council’s institutional transition toward a stewardship paradigm, actively shaping a competitive and innovative healthcare market that directly benefits Saudi citizens. Her clinical background in respiratory therapy and critical care provides nuanced insight into the impact of insurance policy on clinical practice dynamics.

Recognized among the most influential women in healthcare during early 2026, Dr. Bubshait exemplifies the integration of specialized clinical expertise with executive governance within complex regulatory frameworks.

10. Prof. Awad Al-Omari: CEO of Almana Medical Group Advancing Digital Critical Care & Clinical Governance in Saudi Arabia’s Eastern Province

Prof. Awad Al-Omari is recognized for embedding a digital-first strategy into Almana Medical Group, the Eastern Province’s largest healthcare provider. Since June 2025, his leadership has accelerated the integration of AI-enabled radiology services across five hospitals, enhancing diagnostic efficiency and reducing turnaround times substantially. His pioneering Tele-ICU initiative, rooted in prior accomplishments including a Guinness World Record, assures continuous critical care oversight via command center models.

Prof. Al-Omari spearheaded Almana’s introduction of a robotic surgical program, upgrading operating theaters and advancing minimally invasive procedures within the private sector. His concurrent roles as a Professor of Medicine at Alfaisal University and Chairman of the Saudi Critical Care Society enable him to foster clinical scholarship and training that merge data science with frontline medical practice.

A recipient of multiple National Patient Safety Awards, his governance emphasizes robust clinical safety protocols and infection control measures that have set new standards among private healthcare providers in Saudi Arabia. His combined medical and executive education supports his role in positioning Almana as a leader in digital critical care and clinical governance.

Conclusion

The profiles of Saudi Arabia’s top healthcare leaders for 2026 illustrate a multifaceted narrative of governance, innovation, and sectoral integration that is pivotal to the Kingdom's broader health objectives. These leaders demonstrate an intricate balance of forward-looking strategies, operational delivery, and clinical expertise that collectively drive measurable improvements across public and private healthcare domains. Their roles emphasize the importance of accountable stewardship, digital transformation, and value-based care frameworks, reinforcing Saudi Arabia’s commitment to sustainable health system advancements.

Exploring the trajectories and contributions of these key figures offers valuable insight into the evolving leadership philosophies shaping the future of healthcare in Saudi Arabia. Their collective influence underpins the Kingdom’s capability to meet emerging health demands with robust, efficient, and adaptive systems that align with national development goals. Continued observation of these leaders will be essential for understanding the ongoing evolution of healthcare governance and innovation within Saudi Arabia’s dynamic environment.